Literature DB >> 11378004

Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure.

R A de Boer1, H J Siebelink, R A Tio, F Boomsma, D J van Veldhuisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11378004     DOI： 10.1016/s1388-9842(01)00129-5

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  4 in total

1.  A case of variant angina in a patient under chronic treatment with sorafenib.

Authors:  Italo Porto; Andrea Leo; Luca Miele; Maurizio Pompili; Raffaele Landolfi; Filippo Crea
Journal:  Nat Rev Clin Oncol       Date:  2010-05-18       Impact factor: 66.675

2.  Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model.

Authors:  Ying Chen; Xianfei Hong
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

3.  Left ventricular cardiac hemangioma in a patient with chronic heart failure.

Authors:  Hiroyoshi Yamamoto; Shintaro Beppu
Journal:  J Med Ultrason (2001)       Date:  2017-12-26       Impact factor: 1.314

Review 4.  Carvedilol: a review of its use in chronic heart failure.

Authors:  Gillian M Keating; Blair Jarvis
Journal:  Drugs       Date:  2003       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.